HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Pyclen Tri- n -butylphosphonate Ester as Potential Chelator for Targeted Radiotherapy: From Yttrium(III) Complexation to 90 Y Radiolabeling

Abstract : The Y3+ complex of PCTMB, the tri-n-butyl phosphonate ester of pyclen (3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene), was synthesized as well as its Ho3+ and Lu3+ analogues. X-ray diffraction analyses revealed isomorphous dimeric M2(PCTMB)2·9H2O (M = Y, Ho, Lu) structures that crystallize in the centrosymmetric P1 triclinic space group. 1H NMR and UV studies in aqueous solutions indicated that Y3+ complexation is fast, being quantitative in 167 min at pH 3.8 and in 13 min at pH 5.5 (25 °C, acetate buffer, I = 0.150 M, [Y3+] = [PCTMB] = 0.2 mM). 1H NMR DOSY and photon correlation spectroscopy experiments evidenced the formation of aggregates in chloroform with a bimodal distribution that changes slightly with concentration (11-24 and 240-258 nm). The behavior of the acid-assisted dissociation of the complex of Y3+ with PCTMB was studied under pseudo-first-order conditions, and the half-life of the [Y(PCTMB)] complex in 0.5 M HCl at 25 °C was found to be 37 min, a value that decreases to 2.6 min in 5 M HCl. The Y3+ complex of PCTMB is thermodynamically very stable, with a stability constant of log KY-PCTMB = 19.49 and pY = 16.7 measured by potentiometry. 90Y complexation studies revealed fast radiolabeling kinetics; optimal radiolabeling conditions were obtained for 90Y in acetate medium, PCTMB at 10-4 to 10-2 M in acetate buffer pH = 4.75, 15 min at 45-60 °C. In vitro stability studies in human serum showed that [90Y(PCTMB)] is quite stable, with about 90% of the activity still in the form of the radiotracer at 24 h and 80% from 48 h to 72 h. A comparison with other ligands such as PCTA, DOTA, and DTPA already used for in vivo application shows that [90Y(PCTMB)] is an interesting lipophilic and neutral analogue of these reference chelates for therapeutic applications in aqueous and nonaqueous media. © 2016 American Chemical Society.
Document type :
Journal articles
Complete list of metadata

Contributor : Maryline Beyler Connect in order to contact the contributor
Submitted on : Wednesday, May 3, 2017 - 4:03:03 PM
Last modification on : Monday, November 15, 2021 - 2:18:11 PM



Mariane Le Fur, Maryline Beyler, Nicolas Lepareur, Olivier Fougère, Carlos Platas-Iglesias, et al.. Pyclen Tri- n -butylphosphonate Ester as Potential Chelator for Targeted Radiotherapy: From Yttrium(III) Complexation to 90 Y Radiolabeling. Inorganic Chemistry, American Chemical Society, 2016, 55 (16), pp.8003 - 8012. ⟨10.1021/acs.inorgchem.6b01135⟩. ⟨hal-01517774⟩



Record views